INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 108 filers reported holding INHIBRX INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $877,846 | -91.2% | 25,110 | -90.4% | 0.00% | -100.0% |
| Q4 2023 | $9,920,204 | +1572.3% | 261,058 | +707.5% | 0.00% | – |
| Q3 2023 | $593,219 | -87.3% | 32,328 | -82.1% | 0.00% | -100.0% |
| Q2 2023 | $4,681,834 | +34381.0% | 180,348 | -74.9% | 0.00% | -75.0% |
| Q1 2023 | $13,578 | -24.3% | 719,553 | -1.2% | 0.01% | -20.0% |
| Q4 2022 | $17,944 | -99.8% | 728,236 | +22.1% | 0.01% | +66.7% |
| Q3 2022 | $10,706,000 | -0.4% | 596,426 | -37.0% | 0.01% | -14.3% |
| Q2 2022 | $10,749,000 | +550.3% | 947,031 | +1808.0% | 0.01% | +600.0% |
| Q3 2021 | $1,653,000 | -81.1% | 49,634 | -84.4% | 0.00% | -80.0% |
| Q2 2021 | $8,735,000 | +424.3% | 317,401 | +282.3% | 0.01% | +400.0% |
| Q1 2021 | $1,666,000 | -30.1% | 83,018 | +14.8% | 0.00% | -50.0% |
| Q4 2020 | $2,384,000 | +95.7% | 72,304 | +6.8% | 0.00% | +100.0% |
| Q3 2020 | $1,218,000 | – | 67,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,279,995 | $22,976,000 | 5.44% |
| Opaleye Management Inc. | 292,700 | $5,254,000 | 2.17% |
| Perceptive Advisors | 2,887,860 | $51,837,000 | 1.50% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 645,815 | $11,592,000 | 1.11% |
| Birchview Capital, LP | 70,448 | $1,265,000 | 0.89% |
| Soleus Capital Management, L.P. | 363,902 | $6,532,000 | 0.89% |
| Meridian Wealth Advisors, LLC | 122,315 | $2,196,000 | 0.62% |
| Sofinnova Investments, Inc. | 450,177 | $8,081,000 | 0.47% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $95,240,000 | 0.44% |
| Sofinnova Investments, Inc. | 350,000 | $6,283,000 | 0.37% |